Print This Page

Home Health & Medicine Pharmaceutical Intermediate

Raw Powder Moxifloxacin Material Moxifloxacin Hydrochloride Powder Antibiotic Moxifloxacin pictures & photos

Raw Powder Moxifloxacin Material Moxifloxacin Hydrochloride Powder Antibiotic Moxifloxacin

Powder:	Yes
Customized:	Customized
Certification:	GMP, HSE, ISO 9001, USP, BP
Suitable for:	Elderly, Adult
State:	Powder
Purity:	>99%

Samples:	US$ 200/kg 1 kg(Min.Order) \| Request Sample

Customization:	Available \| Customized Request

Contact Supplier

Contact Now

Inquiry Basket

Xi`an Disheng Health Biotechnology Co., Ltd.

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Manufacturer/Factory

Product Description

Company Info.

Overview
Product Description
Product Details
Application&Function
Specification

Basic Info.

Model NO.

D-sung-Moxifloxacin

Product Name

Moxifloxacin

Name

Moxifloxacin Powder

Appearance

White Powder

Color

White

Grade

Pharmaceutical Grade

Assay

HPLC 99%

Application

Pharmaceutical

Specific

COA

Test Method

HPLC UV

Shelf Life

2 Years

CAS No.

151096-09-2

C21h24fn3o4

Logp

2.76430

Psa

83.80000

Einecs

604-773-0

Transport Package

Negotiable

Specification

99%

Trademark

D-sung

Origin

Shaanxi Xi′an

Production Capacity

5000kg/Month

Product Description

Raw Powder Moxifloxacin Material Moxifloxacin Hydrochloride powder Antibiotic Moxifloxacin

Product name	Moxifloxacin
Appearance	White powder
Cas number	151096-09-2
MF	C21H24FN3O4

Fluoroquinolone antimicrobials. DNA topoisomerase inhibitors can be used to treat socially acquired pneumonia caused by Staphylococcus aureus, influenzae, pneumococcus, acute episodes of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibacterial drugs, which is a new generation of broad-spectrum antibiotics. The product has strong antibacterial activity against common respiratory pathogens, such as Streptococcus pneumoniae, haemophilus influenzae, moraxhanella catarrhal and part of Staphylococcus aureus, especially against Streptococcus pneumoniae, antibacterial effect is strong. It is used clinically for the treatment of acute sinus adenitis, acute flare-ups of chronic bronchitis) community-acquired pneumonia, as well as uncomplicated skin infections and skin soft tissue infections. This product is characterized by almost no photosensitive reaction, good tissue penetration and high concentration in lung tissue. It is a good drug for the treatment of respiratory tract infection.